Prevalence of higher-grade dysplasia in persistently high-risk human papillomavirus positive, cytology negative women after introduction of the new cervical cancer screening in Germany

被引:0
|
作者
Laura Berger
Maja Wolf-Breitinger
Christel Weiß
Benjamin Tuschy
Sebastian Berlit
Marc Sütterlin
Saskia Spaich
机构
[1] University Medical Center Mannheim,Department of Obstetrics and Gynecology
[2] Heidelberg University,Department of Medical Statistics and Biomathematics, Medical Faculty Mannheim
[3] Heidelberg University,undefined
来源
Cancer Causes & Control | 2023年 / 34卷
关键词
hrHPV; CIN; VaIN; Colposcopy; Negative cytology; Cervical cancer screening;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:469 / 477
页数:8
相关论文
共 50 条
  • [21] Prevalence of High-Risk HPV Types in Women with Negative Cervical Cytology in a State of Northeast India with a High Burden of Cervical Cancer
    Sailo, Christine Vanlalbiakdiki
    Zami, Zothan
    Ghatak, Souvik
    Nemi, Lalnun
    Lalremmawia, K.
    Pachuau, Lalawmpuii
    Zomawia, Eric
    Siama, Zothan
    Kumar, Nachimuthu Senthil
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2022, 20 (01)
  • [22] CERVICAL CYTOLOGY AND HIGH-RISK HUMAN PAPILLOMAVIRUS (HPV) INFECTION IN THE WOMEN WITH GENITAL CONDYLOMA
    Koo, Y.
    Kim, Y.
    Min, K.
    Hong, J.
    Lee, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 787 - 787
  • [23] High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group
    Gupta, Ruchika
    Hussain, Showket
    Hariprasad, Roopa
    Dhanasekaran, Kavitha
    Verma, Sheel
    Agarwal, Vineeta
    Sandeep
    Parveen, Shahana
    Kaur, Avineet
    Verma, Chandresh Pragya
    Amita
    Dwivedi, Reena
    Singh, Sompal
    Gupta, Sanjay
    ACTA CYTOLOGICA, 2022, 66 (06) : 496 - 506
  • [24] Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer
    Kailash, U.
    Soundararajan, C. C.
    Lakshmy, R.
    Arora, R.
    Vivekanandhan, S.
    Das, B. C.
    BRITISH JOURNAL OF CANCER, 2006, 95 (09) : 1250 - 1257
  • [25] Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer
    U Kailash
    C C Soundararajan
    R Lakshmy
    R Arora
    S Vivekanandhan
    B C Das
    British Journal of Cancer, 2006, 95 : 1250 - 1257
  • [26] Risk of cervical high-grade squamous intraepithelial neoplasia in cytologic negative and persistently high-risk human papillomavirus positive patients according to genotypes: a retrospective single center analysis
    Kipp, Barbara
    Ulrich, Elena
    van Meegen, Carmen
    Schwenzer, Thomas
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [27] Prevalence and Subtype Distribution of High-Risk Human Papillomavirus Among Women Presenting for Cervical Cancer Screening at Karanda Mission Hospital
    Thistle, Paul
    Parpia, Rabea
    Pain, Debanjan
    Lee, Hang
    Manasa, Justen
    Schnipper, Lowell E.
    JCO GLOBAL ONCOLOGY, 2020, 6 : 1276 - 1281
  • [28] Cervical Cancer Screening in Postmenopausal Women: Is It Time to Move Toward Primary High-Risk Human Papillomavirus Screening?
    Kiff, Jaime M.
    Cotter, Madisen
    Munro, Elizabeth G.
    Leonard, Molly E.
    Morgan, Terry K.
    Bruegl, Amanda S.
    JOURNAL OF WOMENS HEALTH, 2021, 30 (07) : 972 - 978
  • [29] The impact of age and high-risk human papillomavirus (hrHPV) status on the prevalence of high-grade cervical intraepithelial neoplasia (CIN2+) in women with persistent hrHPV-positive, cytology-negative screening samples: a prospective cohort study
    Tidy, J. A.
    Lyon, R.
    Ellis, K.
    Macdonald, M.
    Palmer, J. E.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2020, 127 (10) : 1260 - 1267
  • [30] Triage of high-risk HPV positive women in cervical cancer screening
    Ebisch, Renee M. F.
    Siebers, Albert G.
    Bosgraaf, Remko P.
    Massuger, Leon F. A. G.
    Bekkers, Ruud L. M.
    Melchers, Willem J. G.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (10) : 1073 - 1085